Of note, MSK-IMPACT testing was done retrospectively after the patient’s death, on both the supraclavicular lymph node metastasis, which had been found to harbor BRAF K601E, and on the left cervical lymph node excised immediately prior to start of treatment with trametinib. Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.